All this buyout talk is just BS.
LW has a controlling stake by the length of the straight, he has been in forever and he would for one second be considering bailing at anywhere near the current valuations.
Given Acadia's current valuation, what do you think NEU might be worth with a drug that impacts across the whole autism spectrum?
Ann: Neuren and Lanstead agree to pause settlements for 120 days, page-61
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |